The frequency of Foxp3+ Treg decreased significantly in nF-MS patients, both during relapse and while in remission, compared with HS (p = 0.0023 and p = 0.0012, respectively) (Fig. 8). The gene discussed is FOXP3; the disease is myeloid sarcoma.